SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000929638-23-003046
Filing Date
2023-11-08
Accepted
2023-11-08 16:01:18
Documents
2
Period of Report
2023-10-18

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 5326
2 POWER OF ATTORNEY exhibit24.htm EX-24 4869
  Complete submission text file 0000929638-23-003046.txt   11774
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Issuer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOSIGHT THERAPEUTICS 4 HASADOT STREET RAMAT HASHARON L3 4704348
Business Address
Cabilly Yuval (Reporting) CIK: 0001900246 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36138 | Film No.: 231387663